Results 131 to 140 of about 48,845 (222)

Vogt-Koyanagi-Harada-Like Disease with Loss of Visual Acuity due to Sunitinib Treatment Restored after Switch in Therapy: A Case Report

open access: yesCase Reports in Ophthalmology
Introduction: In this paper, we report a case of visual impairment during treatment with sunitinib in a patient with metastatic renal cell carcinoma. Methods: Retrospective chart review was used.
Mechteld C.S. van Olden   +5 more
doaj   +1 more source

Sunitinib specifically augments glucose-induced insulin secretion

open access: yes, 2017
The tyrosine kinase inhibitor sunitinib is used for the treatment of numerous cancers in humans. In diabetic patients, sunitinib lowers blood glucose levels and improves glycaemic control.
Lutz, S.Z.   +11 more
core   +1 more source

Frequency of Clinically Relevant Drug–Drug Interactions Between Tyrosine Kinase Inhibitors and Proton Pump Inhibitors in Patients With Cancer Using Real‐World Data

open access: yesBasic &Clinical Pharmacology &Toxicology, Volume 139, Issue 5, November 2026.
ABSTRACT Background Proton pump inhibitors (PPIs) raise stomach pH, leading to reduced bioavailability of many tyrosine kinase inhibitors (TKIs), thereby affecting treatment outcomes. To what extent this interaction occurs in clinical practice remains underexplored.
Grietje van Elp   +5 more
wiley   +1 more source

A Systematic Intracranial Exposure‐Response Evaluation of Brain‐Penetrant Inhibitors: Informing Dose Selection for Brain Metastases

open access: yesClinical and Translational Science, Volume 19, Issue 11, November 2026.
ABSTRACT Brain metastases (BMs) represent a major clinical challenge due to their high incidence in cancers such as non‐small cell lung cancer (NSCLC) and breast cancer, and the limited efficacy of systemic therapies resulting from inadequate drug penetration across the blood–brain barrier.
Yuqian Zhao, Weize Huang
wiley   +1 more source

Stage‐dependent management paradigms for MEN1‐related Zollinger–Ellison syndrome: A vignette‐based study by the ENETS MEN1 Task Force across 57 expert centers

open access: yesJournal of Neuroendocrinology, Volume 38, Issue 11, November 2026.
Abstract Management of Zollinger–Ellison syndrome (ZES) in patients with multiple endocrine neoplasia type 1 (MEN1) remains controversial, particularly in non‐metastatic disease where the role of surgery is debated. In contrast, treatment of metastatic disease is guided by established systemic approaches.
Kosmas Daskalakis   +27 more
wiley   +1 more source

Natural Product‐Induced Ferroptosis to Overcome Therapy Resistance in Aggressive Cancers

open access: yesChemMedChem, Volume 21, Issue 20, 28 October 2026.
Natural products trigger ferroptosis through iron overload, glutathione depletion, glutathione peroxidase 4 inhibition, and reactive oxygen species accumulation, selectively targeting aggressive, and drug‐resistant cancers. Polyphenols, alkaloids and terpenoids emerge as promising multi‐target agents to overcome therapy resistance and improve future ...
Giorgio Antoniolli
wiley   +1 more source

Spatial transcriptomics tumor microenvironment determinants of tyrosine kinase inhibitor response in renal cell carcinoma: results from a phase 2 clinical trial. [PDF]

open access: yesSignal Transduct Target Ther
Hasanov E   +14 more
europepmc   +1 more source

Cell Village Captures Populational Heterogeneity of Sunitinib Cardiotoxicity. [PDF]

open access: yesCirc Res
Kojic A   +10 more
europepmc   +1 more source

Converting lysosomes into photothermal organelles enables nanoparticle-free tumor ablation via intracellular vapor bubbles. [PDF]

open access: yesSci Adv
Lu T   +17 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy